XJPX
7840
Market cap256mUSD
Jul 10, Last price
1,257.00JPY
1D
0.64%
1Q
-5.28%
Jan 2017
35.31%
IPO
-58.10%
Name
France Bed Holdings Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
France Bed Holdings Co.,Ltd., through its subsidiaries, engages in the medical services and home furnishing and health businesses in Japan. It operates through the Medical Services Business and Home Furnishings and Health Business segments. The company is involved in the development and proposal of products for facilities, such as monitoring and nursing care robots; and manufacture, purchase, rental, retail, and wholesale of nursing care products and welfare equipment such as multi-fit beds, handrails, and multi-position beds, as well as health support products. It also offers linen supply for medical and welfare facilities and hotels; consultations, including nursing care consultations and care plan creation; and electrical stimulation rehabilitation equipment that can be used at home and in medical settings. In addition, the company engages in the operation of showrooms and PR studios; provision of sofas, sofa beds, and bed-type massagers; exhibition sales of furniture, and fashion and jewelry; in-home long-term care support business, long-term care business for residents of specified facilities, dementia-friendly communal living long-term care, small-scale multifunctional in-home care, outpatient care, rental housing for the elderly; and design and construction of guest rooms and lobbies, as well as interior coordination. It offers its products through a range of sales channels, including furniture stores, department stores, interior shops, and hotels. France Bed Holdings Co.,Ltd. was incorporated in 2004 and is based in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||